CLASS II ONGOING Drug recall · Reported 24 Sep 2025 · FDA Enforcement Report

chlorproMAZINE Hydrochloride Tablets, USP, 100 mg recalled

Amerisource Health Services is recalling chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 blisterpack per, distributed nationwide in the US. The recall was initiated on 27 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 1021652, Exp 10/31/2026; 1022539, Exp 01/31/2027; 1023666, Exp 03/31/2027
NDC60687-419, 60687-430, 60687-441, 60687-452, 60687-463
Quantity recalled1,757 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0649-2025
FDA event ID
97533
Recalling firm
Amerisource Health Services, Columbus, OH
Manufacturer
American Health Packaging
Classification
Class II
Status
Ongoing
Recall initiated
27 Aug 2025
FDA classified
15 Sep 2025
Reported
24 Sep 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

27 Aug 2025Recall initiated by company
15 Sep 2025Classified by FDA+19 days
24 Sep 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 60687-452-01 (Individual unit dose blister pack NDC: 60687-452-11)

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 blisterpack per recalled?

Yes. Amerisource Health Services recalled chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 blisterpack per on 27 Aug 2025. The recall is Class II and its status is Ongoing. Recall number D-0649-2025.

Why was it recalled?

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Which lots are affected?

Lot: 1021652, Exp 10/31/2026; 1022539, Exp 01/31/2027; 1023666, Exp 03/31/2027

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Amerisource Health Services

All 69

Other Chlorpromazine recalls

All 25